REGIONAL ADVISORY BOARD POSITION STATEMENT ON OPTIMAL PNEUMOCOCCAL VACCINATION IN ADULTS UPDATE TO 2011 CONSENSUS ON ADULT PNEUMOCOCCAL DISEASE: UPDATE ON OPTIMAL PNEUMOCOCCAL VACCINATION IN ADULTS


Creative Commons License

Ludwig E., ÜNAL S., BOGDAN M., CHLIBEK R., IVANOV Y., KOZLOV R., ...More

CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, vol.21, no.4, pp.233-236, 2013 (SCI-Expanded, SSCI, Scopus)

Abstract

Background: An important development in the field of adult pneumococcal vaccination since the last Consensus Statement, published by the Expert Panel of Central and Eastern Europe and Israel (the Region) in September 2012, was the licensure of the 13-valent pneumococcal conjugate vaccine (PCV13) for adults aged 50 years and older.